| Summary |
Jun 2026 |
Mar 2026 |
Dec 2025 |
Sep 2025 |
Jun 2025 |
Mar 2025 |
Dec 2024 |
Sep 2024 |
Aug 02, 2024 |
|
Promoter
|
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
| Holding |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
75.3% |
| Pledged |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Locked |
0.0% |
0.0% |
26.57% |
26.57% |
26.57% |
26.57% |
100.00% |
100.00% |
100.00% |
|
FII
|
1.9% |
1.4% |
1.1% |
2.3% |
4.2% |
5.8% |
6.4% |
7.3% |
5.3% |
|
DII
|
13.4% |
14.4% |
14.4% |
9.3% |
8.9% |
7.4% |
7.0% |
7.5% |
7.6% |
| Mutual Funds |
9.77% |
10.95% |
11.23% |
6.44% |
6.73% |
6.11% |
5.54% |
5.18% |
3.07% |
| Banks |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1.96% |
| Insurance |
0.37% |
0.60% |
0.65% |
0.63% |
0.61% |
0.66% |
0.67% |
1.72% |
1.39% |
| Others |
3.30% |
2.81% |
2.53% |
2.21% |
1.51% |
0.62% |
0.78% |
0.63% |
1.17% |
|
Public
|
6.7% |
6.3% |
6.5% |
10.5% |
8.9% |
8.8% |
8.6% |
7.1% |
9.1% |
|
Others
|
2.7% |
2.7% |
2.7% |
2.7% |
2.7% |
2.7% |
2.8% |
2.7% |
2.8% |
Shareholding data of Akums Drugs & Pharmaceuticals Ltd. is not available.